Brian Molidor Brian Molidor is Editor at Social News Watch. Find him on Twitter, Facebook, and Pinterest.

Cerevast raises $10 million for its new therapeutic headframe device

35 sec read

Redmond biotech company Cerevast Therapeutics has raised $10 million as it continues to test a headset it hopes will one day be used to treat stroke patients. That brings the company’s total fundraising up to nearly $32.5 million, according to company CEO Bradford Zakes. The company was formed in 2009 and announced earlier this year it had passed its first interim safety analysis as it rolls out trials of its “Clotburst ER” device. 

Cerevast Therapeutics, a 5-year-old Redmond company that’s developing a novel approach for treating stroke patients with ultrasound, has raised $10 million in fresh funding, according to a filing with the SEC. Led by Bradford Zakes, Cerevast was formed in 2009 after the company purchased the assets of ImaRx Therapeutics. Zakes previously worked at ICOS and Glaxo. Earlier this year, the company said that its device passed four independent safety reviews, and that it continued to move forward with clinical studies. Here’s how the company describes the ClotBuster device, which attaches to a patient’s head.

Source
Avatar of Brian Molidor
Brian Molidor Brian Molidor is Editor at Social News Watch. Find him on Twitter, Facebook, and Pinterest.

Google and Huawei might be working on a new…

Google and Huawei might be joining forces once again. According to a tweet from Evan Blass, once of the most respected leakers in the...
Avatar of Brian Molidor Brian Molidor
1 min read

Xiaomi might unveil its first smartwatch later this week

If Apple did it, you can bet your ass that Xiaomi is going to do it too. In all fairness, the majority of Apple’s...
Avatar of Rocco Penn Rocco Penn
1 min read

Check out the OnePlus smartwatch that will never exist

In the two years since OnePlus exploded onto the smartphone scene with the OnePlus One, rumors that the company is working on everything from a...
Avatar of Rocco Penn Rocco Penn
45 sec read

Leave a Reply

Your email address will not be published. Required fields are marked *